Juan Jesús
Cruz Hernández
Profesor Emérito Honorífico
Roberto Andrés
Escala Cornejo
Investigador en el periodo 2016-2018
Publicaciones en las que colabora con Roberto Andrés Escala Cornejo (8)
2023
-
Uso de anakinra en el tratamiento de la infección respiratoria grave por SARS-CoV-2
Reumatologia clinica, Vol. 19, Núm. 2, pp. 121
2022
-
Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy
Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 3, pp. 88
-
Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis
Biomedicines, Vol. 10, Núm. 2
2021
-
Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab
Reumatologia Clinica, Vol. 17, Núm. 10, pp. 559-561
2020
-
Management of Febrile Neutropenia Associated with SARS-CoV-2 Infection in a Patient with Cancer
JCO Oncology Practice
-
Reply to A. Lasagna et al
JCO Oncology Practice
2018
-
Large cell neuroendocrine carcinoma of the lung with atypical evolution and a remarkable response to lutetium Lu 177 dotatate
Annals of Nuclear Medicine, Vol. 32, Núm. 8, pp. 568-572
-
Renal Cell Carcinoma Associated With Xp11.2 Translocation/TFE3 Gene-fusion: A Long Response to mammalian target of rapamycin (mTOR) Inhibitors
Urology, Vol. 117, pp. 41-43